Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Envue Medical Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Envue Medical Inc (FEED) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q1 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
Share of combined sales, Q1 2026
Revenue Growth Y/Y
-
Q1 2026
Net Margin
-3,368.76 %
Q1 2026

Key Findings: Envue Medical Inc vs Its Competitors

  • Scale: Envue Medical Inc ranks #189 of 247 companies by market capitalization in the Medical Equipment & Supplies industry, holding 0.0% of industry market cap.
  • Peer revenue share: Envue Medical Inc accounted for 100.0% of combined revenue among its tracked peer group.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

FEED Sales vs. its Competitors, Q1 2026

Envue Medical Inc generated 100.00 % of the combined sales of its peer group.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/FEED/competitors
https://api.csimarket.com/api/v1/companies/FEED/relationships
https://api.csimarket.com/api/v1/companies/FEED/similar
Programmatic access for models, analytics, and integration workflows.

Envue Medical Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Envue Medical Inc - - - Yes
High-Confidence Competitors (2) 50% 100% 50% 0%
Similar-Size Competitors (10) 17% 63% 50% 44%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q1 2026

100%market share
  • Envue Medical Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Envue Medical Inc and its 0 tracked competitors.

See Envue Medical Inc's full market share breakdown »

FEED Stock Performance relative to its Competitors

FEED Competitors (weighted) Percent change over the selected range

Envue Medical Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
0%beat U.S.A. 500
High-Confidence
(0 of 1)
14.3%beat U.S.A. 500
Similar-Size
(1 of 7)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Envue Medical Inc -89.10 % Underperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (1) 40.4% 63.2%
Similar-Size Competitors (7) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Envue Medical Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

FEED Stock Performance relative to High-Confidence Competitors

FEED High-Confidence Competitors (equal-weighted, 2) Percent change over the selected range

FEED Stock Performance relative to Similar-Size Competitors

FEED Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

Envue Medical Inc's Comment on Competition and Industry Peers

ENvue operates in a competitive industry where it occasionally replaces competitor products owned by customers without financial compensation, except for feeding tubes. The replaced competitor products are utilized for training and research purposes. The competitive environment includes barriers such as regulatory constraints, the necessity for marketing, distribution, and sales capabilities, and extended timeframes for market penetration. Competitors may develop superior technologies that provide competitive advantages. To compete effectively, particularly against large companies, ENvue maintains sales and marketing infrastructure and appropriate distribution channels.

Envue Medical Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Alliqua Biomedical, Inc. Named by the company 85% 2022 to 2026 3
Misonix Inc. Named by the company 85% 2022 to 2026 3
Arobella Medical, LLC Named by the company 85% 2022 to 2026 3
Smith and Nephew plc Named by the company 85% 2022 to 2026 3
Convatec Inc. Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Envue Medical Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

Get the full CSIMarket dataset: Subscribe API License